Neuromodulation: Technology at the Neural Interface

Background: Deep brain stimulation (DBS) is a widely used therapy for neurologic and psychiatric disorders. Conventional DBS delivers highly regular stimulation patterns that suppress pathological activity but can induce stimulation-related side effects, limiting the therapeutic window. Introducing controlled temporal variability through stochastic pulse timing may represent an alternative programming dimension to improve tolerability while preserving clinical benefit. Methods: An adult in their 60's with bilateral Vim DBS underwent evaluation of tonic, pink-noise, and white-noise stimulation patterns delivered through his chronically implanted Boston Scientific Genus system using the Chronos research platform. We assessed tremor and stimulation-induced side effects using accelerometry, spiral drawing tasks, standardized speech recordings, and patient-reported paresthesias. Results: Pink noise stimulation preserved meaningful tremor suppression while improving tolerability compared with conventional tonic 130 Hz stimulation. Under tonic stimulation, dysarthria and paresthesias were prominent at 2.0 mA, narrowing the usable therapeutic window. In contrast, pink noise maintained tremor control across the same amplitude range with reduced side-effect burden. White noise stimulation demonstrated intermediate effects, providing improved tolerability relative to tonic stimulation but less tremor suppression than pink noise. Findings were consistent across accelerometry and functional drawing tasks. Conclusion: This study provides first-in-human evidence that temporally structured stochastic pulse timing can preserve therapeutic benefit while expanding the tolerable stimulation range relative to tonic DBS. These findings suggest that temporal structure represents a clinically meaningful programming dimension that may broaden the DBS therapeutic window using software based updates to existing hardware. Further evaluation in larger cohorts is warranted

Myofascial pain syndrome (MPS) is a major cause of chronic neck pain, with tissue ischemia implicated as a contributing factor. This prospective, single-arm interventional study evaluated the analgesic effect of ultrasound-guided fascia hydrorelease (US-FHR) performed around arteries supplying the neck in patients with chronic neck MPS. Thirteen adults (median age 53.0 years; 38.5% female) underwent US-FHR targeting the perivascular fascia of either the transverse cervical or dorsal scapular artery using 2 mL of normal saline. Pain intensity was assessed by visual analog scale (VAS) at rest and during movement; disability by the 5-item Pain Disability Index, Japanese version (PDI-5-J); and arterial blood flow volume before and after the procedure. The primary outcome, pain VAS during movement, decreased from 49.0 mm (interquartile range [IQR], 44.5-64.0) at baseline to 22.0 mm (IQR, 14.5-31.5) at 15 min and 22.0 mm (IQR, 14.0-34.0) at 1 week (Hodges&-Lehmann median difference, 30.5 mm [95% CI, 24.5 to 36.5] and 28.5 mm [95% CI, 18.5 to 37.0]; both P < 0.001). Pain VAS at rest improved from 21.0 mm (IQR, 13.0-43.5) to 8.0 mm at 15 min and 1 week (median difference, 14.5 mm [95% CI, 9.0 to 24.0; P = 0.001] and 13.5 mm [95% CI, 6.0 to 21.0; P = 0.007]). PDI-5-J decreased from 17.0 (IQR, 10.5-23.0) to 13.0 (IQR, 4.0-17.5) at 1 week (median difference, 5 [95% CI, 2 to 8; P = 0.004]). Blood flow volume increased from 11.2 mL/min (IQR, 4.5-14.4) to 17.2 mL/min (IQR, 6.1-23.7) immediately after US-FHR (median difference, +4.1 mL/min [95% CI, +2.5 to +8.9; P = 0.001]), although transient. One patient experienced transient bleeding that was promptly controlled. In this single-arm feasibility study, US-FHR around the target artery was simple and safe to perform and was associated with reduced neck pain. Because the study lacked a control group, these preliminary findings should be regarded as hypothesis-generating and require confirmation in controlled trials; they may also inform the future evaluation of MPS in other anatomical regions. Trial registration: UMIN Clinical Trials Registry, UMIN000053612.

Background: Chronic pain is a multidimensional condition that often persists despite conventional treatment and adversely affects multiple domains of daily life. Music listening has emerged as a promising non-pharmacological intervention, with accumulating evidence supporting its beneficial effects on pain and associated psychological outcomes. However, despite growing evidence of efficacy, the translation of music listening into routine clinical practice remains limited, partly because intervention reporting has received comparatively little attention. Objective: To evaluate the effectiveness of music listening interventions for chronic pain and systematically assess the methodological quality and completeness of intervention reporting to identify barriers to reproducibility and clinical implementation. Methods: Systematic searches were conducted in PubMed, Cochrane Library, CINAHL, and Web of Science through June 2025, with no date restrictions on publication. Randomized controlled trials involving adults with chronic pain receiving music listening interventions were included. Two independent reviewers screened studies, extracted data, and assessed risk of bias. Intervention reporting was evaluated using the TIDieR checklist, and a random-effects meta-analysis was performed for pain intensity outcomes. Results: Ten RCTs involving 538 participants were included. Music listening interventions varied substantially in delivery, duration, and music selection procedures, reflecting considerable heterogeneity in intervention design. Most studies reported significant improvements in pain and psychological outcomes. Meta-analysis of eight trials (10 effect estimates), demonstrated a moderate reduction in pain intensity (SMD = -0.53, 95% CI: -0.96 to -0.11, p = 0.014; I2 = 76.2%). Although intervention rationale and procedures were generally well described, reporting of intervention modifications, treatment fidelity, and adherence was frequently incomplete. These reporting deficiencies may compromise reproducibility and limit translation into clinical practice. Conclusions: Music listening appears to be a safe, accessible, and scalable non-pharmacological intervention for chronic pain management, with benefits extending beyond pain reduction to psychological wellbeing, quality of life, and functioning. However, incomplete reporting of key intervention components may limit reproducibility and hinder clinical implementation. Future trials should adopt standardized and transparent reporting standards to facilitate implementation into clinical practice.

Modern cochlear implants (CIs) use pulsatile stimulation to restore hearing for individuals with severe hearing loss. CIs provide robust speech recognition in quiet but poorly represent temporal fine structure (TFS), needed for challenging listening situations. Analog stimulation preserves the acoustic waveform and may better encode TFS, yet it has not been evaluated combined with modern current-focusing strategies. We compared neural responses in the inferior colliculus (IC) evoked by CI stimuli consisting of 100 pulses/s biphasic pulse trains and 100 cycles/s sinusoidal analog stimulation with monopolar, bipolar, and tripolar electrode configurations in urethane-anesthetized guinea pigs. Following cochlear implantation, multiunit activity was recorded from the tonotopic axis of the central nucleus of the IC using 16-channel silicon probes. Detection thresholds, spread of excitation, vector strength, sustained response percentage, and temporal response properties were quantified. Analog stimulation consistently evoked significantly lower activation thresholds than pulsatile stimulation while maintaining comparable or sometimes narrower spatial selectivity across stimulation modes. In contrast, analog stimulation generated lower vector strength, larger tonic response components, and a pronounced level-dependent polarity effect. At low stimulus levels, responses were dominated by the cathodic phase of the sinusoidal waveform, whereas increasing stimulus level responses were elicited by both phases, producing synchronization at twice the stimulus frequency. These findings demonstrate that stimulation waveform strongly influences temporal coding while having relatively little effect on the spatial distribution of neural activation. These results provide a physiological basis for reexamining analog stimulation as an alternative strategy for cochlear implant sound coding.

Transcranial photobiomodulation (PBM) is an emerging non-invasive brain stimulation method that is thought to increase neural metabolism by stimulating ATP production by the mitochondria. However, the mechanisms of action and the effects on the human brain are still unclear. In the present study, we investigated the potential of this method to enhance Blood Oxygen Level Dependent (BOLD) responses during the execution of a motor task in young and aged participants. Sixty young and aged participants were included in this single-blinded, sham-controlled, randomised, crossover study. They underwent an fMRI recording before and after 24-min stimulation with a 80-LEDs helmet emitting transcranially red and near infrared light. Post vs Pre BOLD signal was compared between PBM and SHAM, in each group. At baseline, aged participants showed reduced BOLD signal compared to young ones, in key regions of the sensorimotor processing, principally the left primary motor cortex and striatum. Transcranial PBM did not have a real impact in the young group. However in aged participants it increased BOLD signal in some regions that were underactivated compared to the young group at baseline. In particular, regional analysis showed increased BOLD response in the left primary motor cortex, and right dorsal and ventral premotor regions and striatum. These results suggest that transcranial PBM can increase fMRI BOLD activity in the task-related regions, particularly in aged subjects. Further research are needed to distinguish neural from vascular effects in transcranial PBM.

There is growing interest and need for non-invasive stimulation approaches for the treatment of Parkinson's disease (PD) and other neurological conditions. Pilot studies indicate that vibrotactile stimulation on the fingertips may reduce PD motor symptoms (Pfeifer et al., 2021; Syrkin-Nikolau et al., 2018). PD motor symptoms (e.g., rigidity, bradykinesia) are correlated with exaggerated beta power in the subthalamic nucleus (STN), where neurons are excessively synchronized (Brown 2003; Kuhn et al., 2006; Neumann et al., 2016; Yin et al., 2021), but the effect of vibrotactile stimulation on the STN has not been determined. Here, in 12 PD participants in the OFF deep brain stimulation (DBS) and OFF medication state, we investigated how unilateral vibrotactile stimulation applied to the fingertips affects local field potential (LFP) power in STN. We used a within-participants design to expose each participant to a treatment stimulation pattern, termed randomized vibrotactile stimulation (RVS), and a control stimulation pattern, with the order randomized and with intermittent acquisition of STN LFP. RVS yielded a modest but statistically significant 12% (SEM 4.6%) reduction in mean normalized STN beta power and a 48% (SEM 19%) reduction in peak beta power compared to the DBS-off baseline condition and was significantly different when compared to our control stimulus. Furthermore, we identified a biomarker in STN beta power that predicts which participants may benefit from RVS. We observed that participants that exhibited prominent beta peaks had stronger reductions in mean beta power (17% reduction, SEM 6.1%) and peak beta power (55% reduction, SEM 10%). Regressing against the magnitude of the peak in beta provides a moderate prediction of change in mean and peak beta power due to RVS (R2 = 0.58 for mean and 0.52 for peak). We then used our observations to construct a computational model where beta peaks in a simulated STN varied from prominent to diminished. We found that the efficacy of randomized treatments was dependent on the magnitude of beta peaking, mirroring our clinical findings, and showing that RVS may act by reducing intra-neuronal synaptic strengths in STN. Despite robust changes in STN LFP in our study population, we did not observe a significant change in motor symptoms. These results suggest that peripheral vibrotactile stimulation can reduce STN beta power and motivate additional studies to investigate its long-term effects on motor symptoms across a large population of participants.

Effective modulation of cortical-subcortical motor circuits is essential for post-stroke recovery, yet progress has been constrained by the absence of non-invasive tools capable of precisely targeting deep brain structures. In this pilot proof of concept study, we explored the feasibility and preliminary neuromodulatory effects of a 12-minute transcranial focused ultrasound (tFUS) protocol targeting the ipsilesional ventral lateral posterior (VLp) thalamus in ischemic stroke patients. Six individuals with upper-limb hemiparesis received individualized, neuronavigation-guided tFUS. Sensorimotor tracking performance improved signiffcantly after a single session. Concurrent EEG revealed reversible beta-power suppression over the ipsilesional motor cortex and enhanced theta-phase synchronization in frontoparietal networks, both of which were associated with behavioral gains. Resting-state fMRI indicated rebalancing of inter-hemispheric motor networks. These preliminary ffndings suggest that thalamic tFUS can modulate both local and networklevel neural activity and is associated with immediate functional improvement, highlighting its potential as a feasible neuromodulation approach for deep motor circuit engagement in post-stroke rehabilitation.

A test technique for measuring high-frequency transient current components in deep brain tissue is presented. The technique applies a voltage pulse with a high value in dV/dt, generating a corresponding current pulse with high dI/dt that can elicit measurable transient current responses from the electrode/tissue interface and adjacent brain tissue; responses are analyzed in the frequency domain by Fast Fourier Transform at a 200 kHz sampling frequency. The method was motivated by prior evidence that ferritin and neuromelanin in catecholaminergic tissue may support high-frequency conduction properties that have not previously been characterized in vivo. The protocol was applied in 277 measurements across five Sprague Dawley rats at cortical and basal ganglia locations in different locations in the brain. Preliminary spectral results show differences between catecholaminergic regions and cortical tissue that support further development and validation of the method.

Background To build a clinically translatable neonatal seizure detection algorithm using amplitude-integrated electroencephalography (aEEG) and compressed spectral array (CSA). Methods Using a public dataset of annotated neonatal EEGs, features of the aEEG and CSA were extracted from the left and right centroparietal electrodes. These features were then used to train and test three machine learning classifiers, Random Forest (RF), Support Vector Machines (SVM), and Artificial Neural Networks (ANN). Results The trained RF, SVM, and ANN classifiers had areas under the curve (AUC) of 0.80, 0.69, and 0.79 for capturing seizure time periods and an average accuracy of 0.91, 0.90, and 0.92 respectively for capturing seizure and non-seizure time periods. Median accuracy scores were higher among patients without hypoxic-ischemic encephalopathy (HIE; median = 1 for all three classifiers) than HIE patients (median = 0.92, 0.93, 0.93). Conclusion A clinically interpretable aEEG-CSA algorithm is feasible for neonatal seizure detection by extracting standard EEG features and coupling these features with a supervised ML classifier.

Abstract Importance: Drug-resistant focal epilepsy affects approximately 30% of children with epilepsy and carries excess mortality, impaired neurodevelopment, and substantial costs. Epilepsy surgery is underutilized despite proven superiority over medical management. MRI-guided laser interstitial thermal therapy (MRgLITT) is a minimally invasive alternative to open resection, but comparative evidence to guide procedure selection is limited. Objective: To estimate lifetime outcomes and costs of epilepsy surgery versus medical management for pediatric drug-resistant focal epilepsy, and to provide etiology-informed guidance for choosing between open resection and MRgLITT. Design: Markov decision analytic model with a lifetime horizon, parameterized from published systematic reviews, meta-analyses, and cohort studies. Setting: United States, healthcare payer perspective. Participants: Hypothetical cohort of 10-year-old children with drug-resistant focal epilepsy and a seizure focus <3 cm3. Interventions: Best medical management, open resective surgery, or MRgLITT. Main Outcomes and Measures: Quality-adjusted life years (QALYs), lifetime direct medical costs, incremental cost-effectiveness ratios, and lifetime survival. Seizure outcomes were classified as seizure freedom or disabling seizures. Cost-effectiveness was assessed at $100,000/QALY. Results: Both surgical strategies were associated with a 4.6-year survival advantage, 3.6 additional lifetime QALYs, and lower costs than medical management. MRgLITT yielded 22.64 QALYs at $120,943; open resection yielded 22.62 QALYs at $121,650; medical management yielded 19.00 QALYs at $127,471. The difference between MRgLITT and open resection was 0.015 QALYs, reflecting near-equivalent effectiveness; in probabilistic sensitivity analysis, MRgLITT was optimal in 50.3% of iterations and open resection in 38.3%, with neither showing clear superiority. Etiology-specific analyses favored MRgLITT for focal cortical dysplasia and mesial temporal sclerosis, and open resection for tumor-related and cavernoma-related epilepsy. Conclusions and Relevance: Both open resection and MRgLITT were associated with substantially better lifetime outcomes and lower costs than medical management, supporting early surgical referral. Overall effectiveness between surgical approaches was clinically similar, with neither demonstrating clear superiority; the model suggests epilepsy etiology, rather than expected effectiveness alone, should guide procedure selection between MRgLITT and open resection.

Background: Shared decision-making (SDM) is a key component in patient-centered care for people consulting health care due to chronic musculoskeletal pain, including subacromial pain syndrome (SAPS). Limited research has explored how patients, relatives, and healthcare professionals perceive the content and delivery of SDM for managing SAPS in primary care. Thus, this study aims to explore stakeholder perspectives on the content, delivery, and contextual requirements for a context-specific SDM intervention for SAPS, and to identify shared challenges and co-develop ideas to inform intervention development. Methods: We conducted three separate future workshops (patients/relatives, physiotherapists/chiropractors, and general practitioners), each consisting of structured critique, fantasy, and implementation phases. A rapid preliminary analysis of workshop data was followed by semi-structured stakeholder interviews to validate, challenge, or elaborate the findings. All data were analysed thematically using an iterative, reflexive approach. Results: Twenty-eight participants took part across three workshops: patients/relatives (n = 10), physiotherapists/chiropractors (n = 12), and general practitioners (n = 6). Six additional stakeholders provided inputs via subsequent interviews (three physiotherapists, one patient, one relative and one GP). Thematic analysis identified 20 themes and 59 sub-themes, which were refined into two overarching categories: (1) shared barriers to SDM in SAPS care, including diagnostic uncertainty, fragmented clinical care pathways, time constraints, and decision fatigue; and (2) stakeholder visions for future SDM interventions, emphasising continuity, tailored communication tools, and supportive digital ecosystems. Conclusion: Based on stakeholder input, SDM in SAPS care may consider integrating dynamic, integrated systems that account for diagnostic ambiguity, contextual constraints, and varying patient capacities. These findings provide an actionable foundation for co-developing and piloting a context specific SDM intervention for primary care.

Background: Whether a patient's pain improved after emergency department (ED) treatment is read from the record to benchmark EDs, compare drugs, and label research outcomes. It is interpretable only if a post-treatment score is recorded, appropriately timed, and chosen by a fixed rule; its stability across these choices is unknown. Methods: Retrospective measurement study of adult headache visits in a de-identified ED database (MIMIC-IV-ED, 2011-2019). Among treated visits, we quantified reassessment completeness by time window, estimated meaningful relief (a reduction of at least 2 points) under score-selection rules and missing-data assumptions, tested whether reassessment was predictable at treatment, and compared headache with other painful presentations. Results: Among 19,501 visits (15,273 patients), 13,682 (70.2%) were treated. A post-treatment pain score appeared at any time for 77.1% (95% CI, 76.4 to 77.8), but within 2 hours of the analgesic for only 47.9% and within 1 hour for 27.5%. Meaningful relief was 66.9% using the first post-treatment score but 81.0% and 83.4% using the last or lowest score; it was 67.5% under inverse-probability weighting and could be bounded only between 51.8% and 74.4%. Whether a score was recorded was weakly predictable at treatment (area under the curve, 0.566) and unrelated to baseline pain. Completeness was similar across headache strata and comparator painful presentations. In an independent ED (MC-MED, a different EHR), the score-selection effect replicated: relief rose from 71.1% (first) to 80.6% (last) and 83.4% (lowest). Conclusions: Documented pain relief after ED headache treatment was not a stable outcome: it varied with the reassessment window and score-selection rule, was not point-identified for unreassessed patients, and behaved like other painful ED presentations. Programs and research that use documented relief should prespecify the reassessment window, score-selection rule, completeness denominator, and a missing-data range, and favor protocol-timed reassessment.

The slow oscillation (SO) of non-rapid eye movement (NREM) sleep has been implicated in the restorative properties of sleep. Slow oscillatory transcranial direct current stimulation (SO-tDCS), involving a positive oscillatory current applied to the scalp at a peak frequency of 0.75 Hz, has been used to enhance SO power during NREM sleep. We examined whether enhancing SO power with SO-tDCS during a restricted nighttime sleep opportunity would accelerate the restorative properties of sleep during an otherwise insufficient sleep period and help sustain performance during subsequent extended wakefulness. A total of twenty-six healthy young adults (ages 18-39, n=16 females) completed a 15-day study. After 7 baseline nights at home and 3 baseline nights in the laboratory, participants entered the laboratory for 5 consecutive days including a baseline day, a 2-hour nighttime sleep period with participants randomized to the SO-tDCS (n=11) or SHAM (n=15) condition, 46 hours of sleep deprivation, and two recovery nights. In the SO-tDCS condition, stimulation was administered for one hour starting exactly 60 minutes after sleep onset, with intervals of five minutes of continuous stimulation followed by one minute of no stimulation. Polysomnographic recordings were conducted during each sleep period. Performance was assessed using the Psychomotor Vigilance Test (PVT) approximately every 75 minutes across baseline, sleep deprivation, and recovery. Prior to the two-hour sleep opportunity, a Paired Words Associate Task was administered. Participants listened to 54-word pairs and were asked to recall 46 of the word pairs, with up to three attempts to successfully recall at least 60% of word pairs (T0). Recall was also assessed 20- (T20) and 120-minutes (T120) after awakening from the two-hour sleep period. Data were analyzed using mixed-effects ANOVA. PVT performance (defined as mean response time and number of response times greater than 1,000 ms) significantly declined across sleep deprivation with performance degradations peaking in the early morning hours. Participants in the STIM condition demonstrated significantly better performance during sleep deprivation relative to the SHAM condition. On the PWAT, participants in the SHAM condition recalled fewer word-pairs upon awakening relative to T0. In sharp contrast, performance of participants in the SO-tDCS condition did not deteriorate at T20 and was actually improved at T120 relative to T0. We conclude that SO-tDCS can robustly accelerate the restorative properties of sleep and can additionally enhance sleep related memory consolidation when sleep opportunity is restricted.

Background. Despite growing evidence that lifestyle interventions reduce depressive symptoms, the psychological mechanisms underlying these effects remain poorly understood. This study examined whether mindfulness and rumination mediate the antidepressant effects of heated yoga (HY), a multicomponent intervention combining physical activity, attentional training, and thermoregulatory stress. Methods. This prespecified secondary mediation analysis builds on a randomized controlled trial in which 80 adults with moderate-to-severe depression (IDS-CR > 23) were randomized to 8 weeks of twice-weekly HY or waitlist control. Subsamples with complete mediator data contributed to rumination (n = 56) and mindfulness (n = 60) models. Causal mediation analyses with 10,000 bootstrap resamples estimated indirect effects on Week 8 depression severity via Week 4 mediator changes. Sensitivity analyses assessed unmeasured confounding required to nullify observed effects. ClinicalTrials.gov: NCT02607514. Results. As previously reported, HY produced significantly greater IDS-CR reductions at Week 8 versus controls (p < .001). HY was associated with decreased rumination (p < .01) and increased mindfulness (p < .001) at Week 4. Increased mindfulness was statistically consistent with mediating depressive symptom reductions (ACME: -2.71, 95% CI [-5.42, -0.99]), whereas decreased rumination was not (ACME: -2.41, 95% CI [-6.28, 0.43]). Results were resilient to sensitivity analyses. Conclusion. In this RCT of a behavioral lifestyle intervention, mindfulness but not rumination emerged as a statistically significant mediator of depressive symptom reductions, identifying mindfulness as a key candidate mechanism through which multicomponent lifestyle interventions may exert antidepressant effects and suggesting a target for optimizing behavioral treatments for depression.

Background/Objectives: This systematic review examines how different mechanisms of Traumatic Brain Injury (TBI) influence post-injury functional independence and aims to clarify whether recovery patterns vary by injury type. A total of 105 studies (n = 59,621) involving adults with TBI were synthesized. These findings can guide clinicians and researchers in predicting outcomes and effectively customizing rehabilitation plans. Methods: A review following PRISMA standards analyzed English-language studies published from 1975 to 2025, assessed functional outcomes using the Functional Independence Measure (FIM) or the Glasgow Outcome Scale-Extended (GOSE), converted them to z-scores, and aggregated them via a random-effects model with inverse-variance weighting to demonstrate their relevance. Results: Recreational TBIs show the highest functional independence (z = +1.77), followed by MVAs (z = +1.56), with falls (z = +0.70) and assault-related TBIs (z = -0.12) showing moderate outcomes, and TBIs with penetrating trauma (z = -1.15) indicating the most adverse results. Conclusions: TBI mechanisms appear to meaningfully influence long-term post-injury functional independence. Highlighting this can inspire clinicians and researchers to trust these insights to improve prognosis and rehabilitation strategies, underscoring their crucial role in advancing patient care.

Objective: Pediatric epilepsy patients undergoing stereo-electroencephalography (sEEG) for ictal onset evaluation provide a rare window to study the developing brain. While methodological frameworks for task-based sEEG research are well-established in adults, pediatric-specific guidance remains underdeveloped. Furthermore, many pediatric epilepsy patients have comorbidities that might typically exclude them from participating in research. We examine factors that influence research participation and discuss considerations for conducting sEEG research in children. Methods: Here, we present a retrospective analysis of task-based research participation patterns from an NIH-funded study of speech and language representations (1R01DC018579) in 66 patients (ages 4-24) undergoing sEEG monitoring at Texas Children's Hospital to determine whether specific comorbidities influenced research participation. Results: Eighty-nine percent (n=66) of patients approached for consent agreed to participate in the study. Despite high rates of comorbidities including neurocognitive disorder (66.67%), language delay (31.75%), global developmental delay (23.81%), mood disorders (33.33%), ADHD (46.03%), autism spectrum disorder (14.29%) or other cognitive/intellectual disabilities (36.51%), all participants engaged in at least one task. While the majority of these diagnoses did not appear to influence subject participation, global developmental delay was associated with a significant reduction in time spent on active tasks. Discussion: Despite high prevalence of neuropsychological comorbidities among participants, our evidence suggests that these participants contribute meaningfully to studies investigating important developmental questions. We suggest strategies for tailoring task-based research to accommodate the unique needs of individuals in this population. Such practices are important for ensuring that research studies reflect the true diversity of the population.

Introduction: Acute compartment syndrome (ACS) is a limb-threatening complication of extremity trauma that requires timely diagnosis to prevent irreversible muscle and nerve injury. Current diagnostic methods are invasive, intermittent, and operator-dependent. We evaluated the feasibility of a novel, Bluetooth-enabled electrical impedance myography (EIM) device (mAlert, Myolex, Inc., Brookline, MA, USA) for continuous, noninvasive detection of ACS-related tissue changes. Methods: Ten Yorkshire swine underwent anterior tibial compartment monitoring using three ACS models: albumin infusion (ALB, n=3), femoral artery and vein ligation (LIG, n=3), and combined albumin infusion plus ligation (ALB+LIG, n=4). Resistance (R), reactance (X), and phase (P) were measured every minute across 1 to 199 kHz alongside continuous intra-compartmental pressure (ICP) monitoring. Group differences in normalized impedance trends were evaluated using the Kruskal Wallis test with Dunn post hoc correction. As a proof-of-concept human study, nine healthy volunteers wore the device for up to five days to assess electrode durability and signal stability. Tissue ischemia was validated using pimonidazole immunohistochemistry. Results: ALB infusion produced progressive, frequency-dependent decreases in R, X, and P, whereas LIG produced consistent increases in R and X across frequencies. The ALB+LIG model generated mixed responses, reflecting the competing effects of edema and ischemia. Normalized phase slopes differed significantly among groups (H=6.14, p=0.046), with post hoc testing showing significant divergence between the ALB and LIG models (p=0.041). Control limbs remained stable throughout monitoring. Pimonidazole staining confirmed hypoxic injury in the intervention limb. In the human pilot study, three participants completed five days of monitoring, demonstrating sustained signal acquisition, while electrode degradation limited data collection in the remaining participants. Conclusions: This preliminary feasibility study demonstrates that wearable EIM can continuously detect model-specific physiological changes associated with ACS in a large-animal model. These findings support further development and clinical evaluation of wearable EIM as a non-invasive monitoring technology for early ACS detection in trauma patients.

Objective: To evaluate the efficacy, engagement, and usability of Tune Out, an unguided, self-paced online tinnitus management program, for reducing tinnitus severity in adults with tinnitus. Design: A two-arm, parallel-group randomised controlled trial was conducted with Australian adults reporting diagnosed or self-reported tinnitus. Participants were randomised to immediate access to Tune Out or a waitlist control group. Outcomes were assessed at baseline, 6 weeks, and 12 weeks. The primary outcome was tinnitus severity measured using the Tinnitus Functional Index (TFI). Secondary outcomes included tinnitus handicap, psychological symptoms, program engagement, self-efficacy, and usability. Results: Eighty-eight participants were randomised: 43 to the intervention group and 45 to the waitlist control group. The primary outcome analysis included 63 participants at 12 weeks. A significant Group x Time interaction was observed for TFI total score, indicating greater reductions in tinnitus severity over time in the intervention group compared with waitlist control, F(2, 102.57) = 5.95, p = .004, partial 2= .104. Significant effects were also observed for tinnitus handicap, F(2, 106.76) = 4.12, p = .019, partial 2 = .072. Effects on psychological symptoms were less consistent, although anxiety showed a significant Group x Time interaction, F(2, 116.85) = 3.63, p = .030, partial 2 = .059. At 12 weeks, 23.1% of intervention participants achieved a clinically meaningful reduction in tinnitus severity compared with 5.4% of controls. Program use was highly variable, with a median use of 1.10 hours, and 25.6% of intervention participants recording no use. Usability ratings were favourable among respondents, with a mean System Usability Scale score of 73.13. Conclusions: Tune Out demonstrated preliminary efficacy for reducing tinnitus severity and tinnitus handicap compared with waitlist control. Effects on broader psychological symptoms were less consistent. Although usability was rated positively, low and variable engagement highlights the need for strategies to support uptake and sustained use in unguided digital tinnitus interventions.

Study Objectives To develop and initially validate the Circadian Disruption Index (CDI), a self-report measure of circadian disruption, and obtain preliminary evidence of its responsiveness to circadian health education. Methods In Study 1, 244 participants completed a 22-item CDI version and external measures. The sample was randomly divided for exploratory and confirmatory factor analyses. Internal consistency, external associations, and discrimination of poor sleep quality were examined. In Study 2, 72 postgraduate students completed the CDI before and 1 week after a 16-hour circadian health education program in an uncontrolled pre-post design. Results Analyses yielded a 15-item, three-factor structure comprising rhythm stability and light exposure, behavioral habits and diet, and sleep quality and subjective complaints. Total-score internal consistency was acceptable (Cronbach's = 0.871). Confirmatory factor analysis showed a comparative fit index of 0.902 and a root mean square error of approximation of 0.072, although the Tucker-Lewis index was 0.882. CDI scores correlated with sleep quality, chronotype, corrected midsleep on free days, depression, and anxiety, but not social jetlag. The area under the curve for poor sleep quality was 0.807 (95% confidence interval, 0.753-0.862), with an exploratory cutoff of [&le;] 23. In Study 2, CDI scores decreased from 22.26 to 19.88 (p = 0.002; Cohen's dz = 0.36). Conclusions The CDI demonstrated satisfactory internal consistency, a meaningful multidimensional structure, and responsiveness to short-term changes following circadian health education, supporting its potential utility for assessing circadian disruption and monitoring circadian-related behavioral changes.

Study Objectives. To determine whether sleep-related respiratory disruption is associated with regionally specific alterations in sleep spindle topography and whether hypopnea-sensitive spindle features are associated with attentional performance in children. Methods. We recorded overnight high-density EEG in children across a wide range of respiratory disruption severity. Slow and fast spindle metrics were extracted per channel, and channel-wise regression models characterized topographic associations with hypopnea index (HI). Cluster-based permutation testing controlled for multiple comparisons. Hierarchically defined regions of interest were tested as predictors of attentional performance on the Test of Variables of Attention (TOVA). Results. Canonical slow-anterior and fast-posterior spindle organization was detectable across the cohort. Two HI-related topographic effects survived cluster-based permutation correction: higher HI was associated with shortened anterior fast spindle duration and with slower anterior slow spindle peak frequency. In cognitive models, anterior fast spindle duration was the strongest and most consistent predictor of attentional performance, associated with higher signal detection sensitivity, fewer omission errors, and fewer commission errors. By contrast, slow spindle peak frequency showed no attentional associations. Conclusions. Pediatric respiratory disruption is associated with regionally specific alterations in spindle morphology rather than global spindle reduction. Shortened anterior fast spindle duration showed convergent respiratory and attentional associations, suggesting that localized spindle integrity may provide a neurophysiological marker of cognitive vulnerability in pediatric sleep-disordered breathing beyond conventional clinical respiratory metrics.